Wed, Aug 14, 8:57 PM (153 days ago)
On August 14, 2024, Biofrontera Inc. filed a Form 8-K with the SEC, reporting its financial and operational results for the second quarter of 2024. The announcement included non-GAAP financial measures, with reconciliations to GAAP figures provided as required by Regulation G. The report highlights the company's performance metrics for the three and six months ending June 30, 2024. The filing also confirms that Biofrontera is classified as an emerging growth company. The press release is attached as Exhibit 99.1, but it is noted that the information is furnished and not filed under the Exchange Act, meaning it does not carry the same legal obligations. This update may influence investor sentiment and stock performance, as stakeholders assess the company's financial trajectory and operational health.